OssDsign AB (Publ) announced that the company has been awarded a new group purchasing (GPO) agreement for Bone and Bone Substitute Implantable Products with Premier Inc. The agreement is for a period of three years. Effective July 1, 2024, the agreement allows Premier members, at their discretion, to take advantage of special pricing and terms pre-negotiated by Premier for OssDsign's nanosynthetic bone graft OssDsign Catalyst.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
9.22 SEK | -4.36% | -8.71% | +15.25% |
05-14 | Transcript : OssDsign AB, Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | OssDsign AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+15.25% | 87.01M | |
+8.29% | 124B | |
-5.19% | 11.17B | |
+4.83% | 9.17B | |
-22.04% | 4.71B | |
+8.39% | 3.44B | |
-6.28% | 2.88B | |
-10.23% | 2.11B | |
-5.99% | 2.09B | |
-22.62% | 1.8B |
- Stock Market
- Equities
- OSSD Stock
- News OssDsign AB
- OssDsign AB Wins Long-Term Agreement with Premier, Inc